BioTrove, Inc. Screens Two Million Samples Using RapidFire(TM) Lead Discovery, A Label Free High-Throughput Mass Spectrometry Platform For Intractable Drug Targets; Four Clients To Present Data At Upcoming Society For Biological Sciences Meeting

WOBURN, Mass.--(BUSINESS WIRE)--Sept. 12, 2006--BioTrove, Inc. announced today the successful screening of more than two million individual samples using their RapidFire(TM) Lead Discovery System. RapidFire(TM) is a unique, mass spectrometry-based, high-throughput screening platform that facilitates label-free screening of challenging drug targets using native substrates.